FDCDDQ
BIOL

Federation des caisses Desjardins du Quebec’s Biolase, Inc. BIOL Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-37
Closed -$7 – 2598
2024
Q1 		$7 Hold
37
– – ﹤0.01% 2394
2023
Q4 		$42 Hold
37
– – ﹤0.01% 2337
2023
Q3 		$69 Buy
+37
New +$196 ﹤0.01% 2330
2018
Q2 		– Hold
0
– -$1 – 2254
2018
Q1 		– Hold
0
– – – 2149
2017
Q4 		– Hold
0
– – – 2132
2017
Q3 		– Hold
0
– – – 2085
2017
Q2 		– Hold
0
– – – 2147
2017
Q1 		– Hold
0
– – – 1770

Other funds holding BIOL

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BIOL Position: Q2 2024 in Review

Federation des caisses Desjardins du Quebec sold out of Biolase, Inc. (BIOL) in Q2 2024, closing a stake of 37 shares — an estimated $7 sold.

Federation des caisses Desjardins du Quebec first reported a position in BIOL in Q3 2023 and held it in 3 quarters. The position peaked at $69 in Q3 2023. 2 funds tracked by Wall St. Rank hold BIOL as of Q2 2024.

  • Federation des caisses Desjardins du Quebec reported no remaining Biolase, Inc. position as of Q2 2024 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 37 Biolase, Inc. shares in Q2 2024, an estimated $7.
  • Federation des caisses Desjardins du Quebec first reported a position in Biolase, Inc. in Q3 2023 and held it in 3 quarters.
  • Federation des caisses Desjardins du Quebec's Biolase, Inc. position peaked at $69 in Q3 2023.
  • 2 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2024, filed 14 Aug 2024.